Acro Biomedical Co annual revenue
2017
2018
2019
2019
2020
2021
2022
2023
2024
2025
Acro Biomedical Co reported $0 in revenue for fiscal 2025.
View full Acro Biomedical Co company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | −$658,500 | −100.00% |
| 2022 | 2022-12-31 | $658,500 | −$539,000 | −45.01% |
| 2021 | 2021-12-31 | $1.2M | $509,536 | +74.06% |
| 2020 | 2020-12-31 | $687,964 | $494,428 | +255.47% |
| 2019 · Dec 31 | 2019-12-31 | $193,536 | −$1.2M | −85.71% |
| 2019 · Sep 30 | 2019-09-30 | $1.4M | −$6.7M | −83.11% |
| 2018 | 2018-09-30 | $8.0M | $7.5M | +1471.47% |
| 2017 | 2017-09-30 | $510,000 | — | — |
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Acro Biomedical Co filings at SEC.gov ↗